Allianz Bio. offer comprehensive reagent services to support cutting-edge research and therapeutic development. Enabling precise and efficient genetic engineering to ensure high purity and quality for preclinical and clinical applications. With state-of-the-art technology, rigorous quality control, and scalable solutions tailored to meet the needs of academic, biotech, and pharmaceutical clients, accelerating innovation from discovery to development.

To accelerate discovery and innovation across the life sciences, our principals offer antibody sequencing solutions unlocking detailed insights into variable regions for therapeutic antibody development. While whole plasmid sequencing offers complete, high-accuracy plasmid validation, ensuring confidence in every construct.

Custom library services tailored for functional genomics and gene perturbation studies. Supporting CRISPR KO, CRISPRa and CRISPRi applications, with flexible design options for targeting specific genes, using custom tracrRNAs to inducible or constitutive expression options. With over 15 years of expertise, Cellecta ensures high-quality, scalable solutions that empower researchers to conduct focused or genome-wide genetic screens with confidence and precision.

A comprehensive bioinformatics analysis services encompass functional genetic screening analysis, adaptive immune receptor profiling, and targeted RNA-Seq analysis. For functional screens utilizing CRISPR or RNAi libraries for identifying essential genes and pathways, facilitating the interpretation of complex screening data.

Analytical services to support biopharmaceutical research and development providing detailed kinetic and affinity analyses of biomolecular interactions, characterizing antibody-antigen binding, receptor-ligand interactions, and other molecular engagements. These label-free techniques deliver real-time data, aiding in the optimization of therapeutic candidates. Additionally, ensure the consistency and reliability of protein products through rigorous assessments, including purity, identity, and bioactivity evaluations.

Our principals offer advanced cell line services to support genetic research, drug development, and virology studies. Providing custom cells, with validated activity using proprietary assays, targeted gene editing for functional screening and pathway analysis. Additionally allowing for a wide range of modifications, including reporter integration and inducible gene expression systems. Together, these services deliver reliable, customizable platforms for in-depth cellular analysis and genetic engineering across various research applications.

Specialized assay development service to provides high-affinity, high-specificity antibodies essential for pharmacokinetic (PK) and anti-drug antibody (ADA) assays. These antibodies are tailored for various therapeutic modalities, including monoclonal antibodies, bispecific antibodies, antibody-drug conjugates (ADCs), and CAR-T therapies, facilitating accurate drug level monitoring and immunogenicity assessments.

Azenta and Cellecta provide end-to-end construct services to support molecular biology, gene editing, and gene therapy research. Offering high-quality prep services to PCR and sequencing services to streamline cloning workflows. Viral packaging services, ensure efficient delivery of plasmids and viral particles. With all constructs are available as plasmids or pre-packaged viral particles for seamless experimentation.